NEW YORK (GenomeWeb) – BioMérieux today said that its revenues for full-year 2014 rose 7 percent year over year, helped by its BioFire acquisition from a year ago. 

For the 12 months ended Dec. 31, 2014, the Marcy L'Etoile, France-based in vitro diagnostics firm reported total revenues rose to €1.70 billion ($1.90 billion) from €1.59 billion in 2013. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.